THOMAS LLOYD to Dermatomyositis
This is a "connection" page, showing publications THOMAS LLOYD has written about Dermatomyositis.
Connection Strength
0.864
-
Transcriptional derepression of CHD4/NuRD-regulated genes in the muscle of patients with dermatomyositis and anti-Mi2 autoantibodies. Ann Rheum Dis. 2023 08; 82(8):1091-1097.
Score: 0.198
-
Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis. Ann Rheum Dis. 2023 06; 82(6):829-836.
Score: 0.195
-
Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1? autoantibodies. Ann Rheum Dis. 2023 Feb; 82(2):246-252.
Score: 0.189
-
The phenotype of myositis patients with anti-Ku autoantibodies. Semin Arthritis Rheum. 2021 08; 51(4):728-734.
Score: 0.172
-
Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis. Ann Rheum Dis. 2020 09; 79(9):1234-1242.
Score: 0.041
-
Muscle endurance deficits in myositis patients despite normal manual muscle testing scores. Muscle Nerve. 2019 01; 59(1):70-75.
Score: 0.037
-
Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity. Ann Rheum Dis. 2017 04; 76(4):681-687.
Score: 0.031